KALA BIO Quote - KALA

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

5.59

Bid

5.59

Offer

7.02

Volume

74,540

6.46 Day's Range 6.7145

4.21 52 Week Range 10.97

Market Cap

25.771M

Previous Close

6.55

Open

6.68

Last Trade

433

5.59

(formt)

Last Trade Time

Financial Volume

US$ 492,330

VWAP

6.6049

Average Volume (3m)

20,318

Shares Outstanding

4,610,139

Dividend Yield

PE Ratio

-0.73

Earnings Per Share (EPS)

-9.15

Revenue

230k

Net Profit

-42.2M

Kala Pharmaceuticals Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY Mucus Penetrating Particles, technology, with an initial focus on the treatment of eye diseases. AMPPLIFY particles are selectively-... Kala Pharmaceuticals Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY Mucus Penetrating Particles, technology, with an initial focus on the treatment of eye diseases. AMPPLIFY particles are selectively-sized nanoparticles and have proprietary coatings. It has applied the AMPPLIFY technology to create nanosuspensions of loteprednol etabonate, or LE, acorticosteroid designed for ocular applications, resulting in two product candidates. INVELTYS was approved in August 2018 for the treatment of inflammation and pain following ocular surgery and KPI-121 0.25 per cent is in Phase 3 development for the temporary relief of the signs and symptoms of dry eye disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kalarx.com

Headquarters

Watertown, Massachusetts, USA

Founded

KALA BIO Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KALA. The last closing price for KALA BIO was US$6.55. Over the last year, KALA BIO shares have traded in a share price range of US$ 4.21 to US$ 10.97.

KALA BIO currently has 4,610,139 shares in issue. The market capitalisation of KALA BIO is US$30.20 million. KALA BIO has a price to earnings ratio (PE ratio) of -0.73.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.1926	-17.5832276708	6.7826	6.8735	5.59	19818	6.50924109	CS
4	-1.17	-17.3076923077	6.76	7.85	5.59	32808	7.10553231	CS
12	-0.4	-6.67779632721	5.99	7.85	4.95	20318	6.49518115	CS
26	-0.99	-15.0455927052	6.58	7.88	4.21	128605	6.51488015	CS
52	-0.36	-6.05042016807	5.95	10.97	4.21	89289	6.93077584	CS
156	-89.91	-94.1465968586	95.5	100.5	3.5444	770951	33.55417791	CS
260	-197.41	-97.2463054187	203	734	3.5444	1075689	207.87700843	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PDYNPalladyne AI Corporation	US$ 4.59 (129.50%)	83.07M
QMCOQuantum Corporation	US$ 9.11 (126.62%)	39.48M
NANano Labs Ltd	US$ 8.26 (89.02%)	2.03M
XCURExicure Inc	US$ 18.60 (71.27%)	4.59M
SKKSKK Holdings Limited	US$ 1.75 (59.09%)	107.47M
AMIXAutonomix Medical Inc	US$ 6.21 (-54.07%)	946.09k
CETXCemtrex Inc	US$ 0.1146 (-41.74%)	24.39M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	US$ 3.09 (-26.25%)	313.51k
ENSCEnsysce Biosciences Inc	US$ 0.4414 (-25.49%)	4M
ELABElevai Labs Inc	US$ 0.0201 (-0.50%)	425.38M
NVDANVIDIA Corporation	US$ 141.95 (-3.22%)	236.51M
SMCISuper Micro Computer Inc	US$ 33.15 (11.62%)	159.61M
VRPXVirpax Pharmaceuticals Inc	US$ 0.5501 (-6.72%)	159.39M
SOUNSoundHound AI Inc	US$ 8.24 (18.05%)	107.91M